Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Exenatide Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Extended-release injectable suspension
  • 1.4.3 Fast release injectable suspension
• 1.5 Market by Application
  • 1.5.1 Global Exenatide Market Share by Application (2014-2025)
  • 1.5.2 Hospital
  • 1.5.3 Drug store
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Exenatide Market Size
• 2.2 Exenatide Growth Trends by Regions
  • 2.2.1 Exenatide Market Size by Regions (2014-2025)
  • 2.2.2 Exenatide Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Exenatide Market Size by Manufacturers
  • 3.1.1 Global Exenatide Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Exenatide Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Exenatide Market Concentration Ratio (CR5 and HHI)
• 3.2 Exenatide Key Players Head office and Area Served
• 3.3 Key Players Exenatide Product/Solution/Service
• 3.4 Date of Enter into Exenatide Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Exenatide Market Size by Type (2014-2019)
• 4.2 Global Exenatide Market Size by Application (2014-2019)

5 United States

• 5.1 United States Exenatide Market Size (2014-2019)
• 5.2 Exenatide Key Players in United States
• 5.3 United States Exenatide Market Size by Type
• 5.4 United States Exenatide Market Size by Application

6 Europe

• 6.1 Europe Exenatide Market Size (2014-2019)
• 6.2 Exenatide Key Players in Europe
• 6.3 Europe Exenatide Market Size by Type
• 6.4 Europe Exenatide Market Size by Application

7 China

• 7.1 China Exenatide Market Size (2014-2019)
• 7.2 Exenatide Key Players in China
• 7.3 China Exenatide Market Size by Type
• 7.4 China Exenatide Market Size by Application

8 Japan

• 8.1 Japan Exenatide Market Size (2014-2019)
• 8.2 Exenatide Key Players in Japan
• 8.3 Japan Exenatide Market Size by Type
• 8.4 Japan Exenatide Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Exenatide Market Size (2014-2019)
• 9.2 Exenatide Key Players in Southeast Asia
• 9.3 Southeast Asia Exenatide Market Size by Type
• 9.4 Southeast Asia Exenatide Market Size by Application

10 India

• 10.1 India Exenatide Market Size (2014-2019)
• 10.2 Exenatide Key Players in India
• 10.3 India Exenatide Market Size by Type
• 10.4 India Exenatide Market Size by Application

11 Central & South America

• 11.1 Central & South America Exenatide Market Size (2014-2019)
• 11.2 Exenatide Key Players in Central & South America
• 11.3 Central & South America Exenatide Market Size by Type
• 11.4 Central & South America Exenatide Market Size by Application

12 International Players Profiles

• 12.1 AstraZeneca
  • 12.1.1 AstraZeneca Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Exenatide Introduction
  • 12.1.4 AstraZeneca Revenue in Exenatide Business (2014-2019)
  • 12.1.5 AstraZeneca Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Exenatide (marketed as Byetta, Bydureon) is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) medication, belonging to the group of incretin mimetics, approved in April 2005 for the treatment of diabetes mellitus type 2.
In 2018, the global Exenatide market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Exenatide status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Exenatide development in United States, Europe and China.

The key players covered in this study
AstraZeneca
...

Market segment by Type, the product can be split into
Extended-release injectable suspension
Fast release injectable suspension

Market segment by Application, split into
Hospital
Drug store

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Exenatide status, future forecast, growth opportunity, key market and key players.
To present the Exenatide development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Exenatide are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.